27 prescription drugs will now cost less for Medicare recipients
The rebate program begins in April and can save Medicare recipients anywhere from $2 to $390.
LEARN MORESanofi is the latest insulin maker to announce price cap
Sanofi joins Eli Lilly and Novo Nordisk to cap insulin prices. President Joe Biden still wants Congress to enact limits.
Shutterstock
March 17, 2023
Amid pressure from both the public and the Biden administration, a third insulin maker announced it is capping insulin prices. The announcement this week by Sanofi means the three largest insulin producers in the world have instituted price caps in recent weeks.
Eli Lilly and Novo Nordisk previously made similar announcements. Together, they make about 90% of the world’s insulin.
Sanofi said Lantus 100 Units/mL will have a $35 per month cap on out-of-pocket costs for all patients with commercial insurance. The company said Lantus is its most popular form of insulin.
The price cap goes into effect Jan. 1, 2024.
Sanofi says the price cap will drop its price of insulin by 78%.
“Sanofi believes that no one should struggle to pay for their insulin and we are proud of our continued actions to improve access and affordability for millions of patients for many years,” said Olivier Bogillot, head of U.S. general medicines with Sanofi.
The Biden administration welcomed Sanofi’s announcement.
“Sanofi is the latest company to recognize that charging hundreds of dollars for insulin that costs $10 to produce is just wrong, especially when the lives of so many children, parents, and grandparents depend on it,” President Joe Biden said in a statement. “Congress should still pass legislation to ensure everybody can get insulin for no more than $35 per month.”
The announcement comes amid a political battle to cap the price of insulin. Congress passed the Inflation Reduction Act, which included a provision limiting insulin prices for Medicare recipients to $35.
According to the Food and Drug Administration, insulin helps to take the sugar in the blood to other parts of the body. The FDA said that diabetes affects how the body makes and uses insulin.
The Centers for Disease Control and Prevention estimates 37.3 million Americans have diabetes, which accounts for 11.3% of the population.
California to manufacture its own insulin, cap cost at $30
California has partnered with a manufacturer to produce insulin that is expected to save residents hundreds of dollars every month.
68 injuries, 4 eyeball removals tied to recalled EzriCare eye drops
The CDC said anyone using EzriCare Artificial Tears needs to immediately stop as it investigates the incidents.
Pfizer recalls migraine pill packs due to child safety risk
Pfizer is recalling Nurtec ODT 75 milligram tablets because the products are not in child-resistant packaging.
Top Stories
10:24
Why does today's audience say certain fictional characters are gay?
In this segment of "Pop Quiz," Scripps News explores how historians and viewers are speculating about queer subtext in new and old media.
2:50
Los Angeles school support staff at an impasse in higher pay talks
Cafeteria workers, bus drivers and other school support staff employees say the district isn't meeting their requests.
3:01
This basketball magazine is mixing art with 'outlandish' sport stories
Flagrant Magazine is carving out its own space in the sports media industry by mixing abstract basketball art with culture stories from off the court.
